rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Roger D. Dansey

Director

Company insider

Files Form 4 as: Director, Inovio Pharmaceuticals; Director, Nurix Therapeutics; Director, Bicycle Therapeutics; Director, Kronos Bio; President, R&D & CMO, Seagen.

Every Form 4 they filed

In numbers

Trades disclosed
207
Buys
0
Sells
42
Bought
$0
Sold
$35.6M
Companies
5
Companies where not an officer
4
First trade
15 Jun 2018
Last trade
20 May 2026
Last filed
21 May 2026

Companies traded

Where they are an officer
SeagenOfficer · last 14 Dec 20230 buys · 42 sells
Everywhere else they filed: board seats, 10% stakes, other companies
INO Inovio PharmaceuticalsDirector · Biotechnology · last 20 May 20260 buys · 0 sells
NRIX Nurix TherapeuticsDirector · Biotechnology · last 15 May 20260 buys · 0 sells
BCYC Bicycle TherapeuticsDirector · Biotechnology · last 2 Jan 20260 buys · 0 sells
Kronos BioDirector · last 20 Jun 20250 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—41,800 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—34,200 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—41,800 at $0.00filing
20 May 2026filed 21 May 2026INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—34,200 at $0.00filing
15 May 2026filed 15 May 2026NRIX Nurix Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,250 at $0.00filing
15 May 2026filed 15 May 2026NRIX Nurix Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—31,250 at $0.00filing
2 Jan 2026filed 6 Jan 2026BCYC Bicycle TherapeuticsBiotechnologySEC FORM 4 Code A—3,032 at $0.00filing
2 Jan 2026filed 6 Jan 2026BCYC Bicycle Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,065 at $0.00filing
2 Jan 2026filed 6 Jan 2026BCYC Bicycle Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,065 at $0.00filing
2 Jan 2026filed 6 Jan 2026BCYC Bicycle TherapeuticsBiotechnologySEC FORM 4 Code A—3,032 at $0.00filing
6 Nov 2025filed 10 Nov 2025NRIX Nurix Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—50,000 at $0.00filing
8 Sep 2025filed 10 Sep 2025BCYC Bicycle Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
8 Sep 2025filed 10 Sep 2025BCYC Bicycle TherapeuticsBiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
20 Jun 2025filed 20 Jun 2025Kronos Biooption or derivativeSEC FORM 4 Code D—68,000 at $0.00filing
20 Jun 2025filed 20 Jun 2025Kronos Biooption or derivativeSEC FORM 4 Code D—5,868 at $0.00filing
20 Jun 2025filed 20 Jun 2025Kronos Biooption or derivativeSEC FORM 4 Code D—34,000 at $0.00filing
21 May 2025filed 21 May 2025INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code M—2,167 at $0.00filing
21 May 2025filed 21 May 2025INO Inovio PharmaceuticalsBiotechnologySEC FORM 4 Code M—2,167filing
25 Jun 2024filed 26 Jun 2024Kronos Biooption or derivativeSEC FORM 4 Code A—34,000 at $0.00filing
21 May 2024filed 22 May 2024INO Inovio Pharmaceuticalsoption or derivative · BiotechnologySEC FORM 4 Code A—2,917 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed42

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.